For the Quarter Ending March 2026
Ivermectin Prices in North America
- In United States, the Ivermectin Price Index rose quarter-over-quarter in Q1 2026, reflecting elevated production costs.
- The Producer Price Index rose 4.0% in March 2026, increasing the Ivermectin Production Cost Trend.
- Consumer inflation reached 3.3% and retail sales grew 4.0% in March 2026, supporting Ivermectin Demand Outlook.
- Industrial production grew 0.7% and the Manufacturing Index expanded in March 2026, tightening formulation material availability.
- Unemployment stabilized at 4.3% and consumer confidence reached 91.8 in March 2026, sustaining companion animal demand.
- Emergency veterinary demand surged following a federal emergency use authorization for injectable formulations in February 2026.
- Costs for synthesis solvent methanol strengthened while natural gas feedstock costs rose during Q1 2026.
- Conversely, fermentation feedstock sugar weakened in March 2026 and nutrient soybean meal declined in January 2026.
- The national cattle herd contracted and live cattle imports remained restricted in January 2026.
- The Ivermectin Price Forecast indicated upward pressure in Q1 2026 due to tightening domestic solvent inventories.
Why did the price of Ivermectin change in March 2026 in North America?
- Synthesis solvent methanol costs strengthened and domestic inventories drew down significantly during Q1 2026.
- Emergency veterinary demand for injectable formulations surged following federal emergency use authorizations in February 2026.
- The Producer Price Index increased 4.0% in March 2026, elevating energy-intensive pharmaceutical manufacturing expenses.
Ivermectin Prices in APAC
- In China, the Ivermectin Price Index rose quarter-over-quarter in Q1 2026, driven by increased production costs.
- The Ivermectin Production Cost Trend increased during Q1 2026 as the Producer Price Index rose 0.5%.
- The Ivermectin Demand Outlook stabilized in March 2026, supported by a mild 1.0% Consumer Price Index increase.
- Industrial Production grew 5.7% in March 2026, ensuring abundant supply and preventing Ivermectin Price Index spikes.
- Retail sales grew 1.7% while unemployment reached 5.4% in March 2026, softening retail companion animal demand.
- Consumer confidence hit 91.6 in February 2026, while the Manufacturing Index expanded during March 2026.
- Corn starch fermentation feedstock costs for Ivermectin strengthened in Q1 2026 due to firmer domestic values.
- Export volumes of Ivermectin to South Asian markets surged significantly during the Q1 2026 period.
- The Ivermectin Price Forecast remained firm in Q1 2026 as domestic pork and poultry output expanded.
Why did the price of Ivermectin change in March 2026 in APAC?
- Corn starch fermentation feedstock costs strengthened in Q1 2026, pushing overall Ivermectin manufacturing expenses upward.
- Energy and logistics costs for fermentation facilities inched up during Q1 2026, adding price pressure.
- Veterinary antiparasitic demand strengthened in Q1 2026, driven by expanded domestic poultry and pork production.
Ivermectin Prices in Europe
- In Germany, the Ivermectin Price Index fell quarter-over-quarter in Q1 2026, driven by easing upstream production costs.
- The Ivermectin Production Cost Trend declined as producer prices dropped 0.2% in March 2026, softening feedstock expenses.
- Despite a 2.7% CPI rise in March 2026, energy costs for wet-milling glucose feedstocks remained structurally elevated.
- Stagnant industrial production at 0.0% in February 2026 aligned with abundant standard soybean feedstock supply availability.
- The Ivermectin Demand Outlook remained steady, supported by a 0.7% retail sales growth in February 2026.
- A stable 4.2% unemployment rate in February 2026 sustained pharmaceutical grade glucose demand throughout Q1 2026.
- The manufacturing index expanded in March 2026, while European ethanol solvent inventories remained balanced amid restrained trading.
- Negative consumer confidence at -24.7 in March 2026 kept the Ivermectin Price Index suppressed despite discounted imports.
- The Ivermectin Price Forecast reflected downward pressure in Q1 2026 due to persistent soybean fermentation input oversupply.
Why did the price of Ivermectin change in March 2026 in Europe?
- Ethanol extraction solvent costs declined in Q1 2026 amid discounted import offers and improved logistics.
- Soybean-derived fermentation feedstock costs softened significantly following robust global crushing volumes throughout the Q1 2026 period.
- Producer prices dropped 0.2% in March 2026, allowing lower production costs to pass down supply chains.
For the Quarter Ending December 2025
Ivermectin Prices in North America
- In the United States, the Ivermectin Price Index rose in Q4 2025, influenced by increased chemical selling prices in October 2025.
- Ivermectin production costs increased, with CPI rising 2.7% in December 2025 and PPI 3.0% in November 2025.
- Ivermectin demand outlook was supported by a 2.0% industrial production rise in December 2025, especially in agriculture.
- Energy costs for Ivermectin production climbed, with US natural gas spot prices revised upward for Q4 2025.
- US chemicals output contracted in October 2025, contributing to supply fragility for Ivermectin in 2025.
- Retail sales increased 3.3% in November 2025, indirectly supporting Ivermectin demand in pet care and health.
- US pharmaceutical exports and imports both declined substantially in October 2025, impacting Ivermectin trade flows.
- Consumer confidence, at 89.1 in December 2025, indicated a cautious outlook for discretionary spending.
Why did the price of Ivermectin change in December 2025 in North America?
- Rising input costs were evident from 2.7% CPI year-over-year in December 2025.
- Producer Price Index increased 3.0% in November 2025, indicating higher manufacturing expenses.
- US natural gas spot prices revised upward for Q4 2025, increasing energy production costs.
Ivermectin Prices in APAC
- In China, Ivermectin Price Index fell in Q4 2025, due to producer price deflation and weak domestic demand.
- Ivermectin production costs declined in December 2025, as the Producer Price Index fell 1.9% year-over-year.
- Demand for Ivermectin was supported by a 5.2% rise in industrial production in December 2025.
- Weak domestic demand in Q4 2025, with retail sales growing 0.9% in December, impacted consumption.
- China's Manufacturing Index expanded in December 2025, signaling broader industrial sector growth.
- Ivermectin price trends in Q4 2025 were influenced by structural oversupply in China's chemical industry.
- Medicine exports, including active pharmaceutical ingredients, steadily increased in China through November 2025.
- Raw material inventories declined in October 2025, while industrial electricity prices remained stable in Q4 2025.
- Stable inflation (CPI 0.8% in December 2025) and moderate unemployment (5.1%) did not significantly boost consumer spending.
Why did the price of Ivermectin change in December 2025 in APAC?
- Producer Price Index declined 1.9% in December 2025, reducing Ivermectin production costs.
- Weak domestic demand, with retail sales growing 0.9% in December 2025, pressured Ivermectin prices.
- Structural oversupply in China's chemical industry during 2025 contributed to downward price trends.
Ivermectin Prices in Europe
- In Germany, the Ivermectin Price Index fell quarter-over-quarter in Q4 2025, due to weak demand and declining industrial producer prices.
- Ivermectin production costs declined in December 2025, as the Producer Price Index (PPI) decreased by 2.5% year-over-year.
- Demand outlook for Ivermectin weakened in Q4 2025, with chemical industry domestic and export orders trending weak.
- Consumer confidence was significantly negative at -17.5 in December 2025, despite CPI rising 1.8% year-over-year.
- The Manufacturing Index indicated a contracting trend in December 2025, signaling a slowdown in overall industrial activity.
- Industrial production grew modestly by 0.8% in October 2025; retail sales increased 1.1% in November 2025.
- High energy and raw material costs persisted for Germany's chemical industry in October 2025, influencing production expenses.
- Rising import pressures and Chinese overcapacity exerted downward pressure on Ivermectin prices in Q4 2025.
Why did the price of Ivermectin change in December 2025 in Europe?
- Producer Price Index declined 2.5% year-over-year in December 2025, lowering input costs for Ivermectin production.
- Weak domestic and export orders for German chemicals dampened Ivermectin demand throughout Q4 2025.
- Low consumer confidence at -17.5 in December 2025 affected discretionary spending on related healthcare products.
For the Quarter Ending September 2025
Ivermectin Prices in North America
- In the United States, the Ivermectin Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and declining chemical output.
- Ivermectin production costs increased, influenced by a 2.6% year-over-year rise in PPI in August 2025 and elevated energy costs.
- Demand for Ivermectin faced headwinds from a 3.0% year-over-year CPI increase and declining consumer confidence in September 2025.
- Despite weak overall chemical demand, retail sales increased 5.42% year-over-year in September 2025, supporting some end-use markets.
- Chemical industry inventories shrank in Q3 2025 due to accelerating destocking, impacting overall supply dynamics.
- Industrial production grew only 0.1% year-over-year in September 2025, reflecting subdued activity and a decline in chemical output.
- Foreign orders for the chemical industry declined in Q3 2025, alongside a fall in US exports in July 2025.
- The unemployment rate of 4.3% in September 2025 indicated a stable labor market, influencing labor costs for manufacturers.
Why did the price of Ivermectin change in September 2025 in North America?
- Increased input and raw materials costs, alongside elevated energy prices, drove Ivermectin production expenses.
- A 2.6% year-over-year PPI increase in August 2025 signaled rising producer costs, impacting Ivermectin.
- Declining chemical output in September 2025, coupled with shrinking inventories, tightened supply.
Ivermectin Prices in APAC
- In China, the Ivermectin Price Index fell quarter-over-quarter in Q3 2025, driven by persistent overcapacity and contracting manufacturing activity.
- Ivermectin production costs declined in Q3 2025, as PPI fell by 2.3% in September 2025 and energy costs eased.
- Demand for Ivermectin was supported by 6.5% industrial production growth in September 2025 and a thriving pharmaceutical industry.
- The veterinary medicine market experienced growth in Q3 2025, bolstering Ivermectin demand despite consumer confidence at 89.6.
- Retail sales rose by 3.0% in September 2025, yet CPI fell by 0.3%, indicating mixed signals for Ivermectin demand.
- Stable unemployment at 5.2% in September 2025 sustained consumer spending on healthcare and pet care products.
- Persistent overcapacity in China's chemical industry exerted downward pressure on Ivermectin prices during Q3 2025.
- Corn starch feedstock costs stabilized in Q3 2025, influenced by improved logistics and easing energy costs.
Why did the price of Ivermectin change in September 2025 in APAC?
- Falling PPI by 2.3% in September 2025 reduced raw material costs for Ivermectin producers.
- Contracting Manufacturing Index in September 2025 signaled weaker industrial demand for chemical inputs.
- Persistent overcapacity in China's chemical industry during Q3 2025 exerted downward pressure on prices.
Ivermectin Prices in Europe
- In Germany, the Ivermectin Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting industrial activity.
- Ivermectin production costs faced persistent industry-wide increases in Q3 2025, despite moderating European natural gas prices.
- Ivermectin demand outlook weakened in Q3 2025, as the Manufacturing Index contracted and industrial production declined.
- Inflationary pressures, indicated by a 2.4% year-over-year CPI in September 2025, affected operational expenses.
- Producer input costs showed deflationary trends, with PPI declining by 1.7% year-over-year in September 2025.
- Significantly negative consumer confidence of -23.6 in September 2025 suggested cautious spending, pressuring demand.
- German chemical and pharmaceutical industry production declined in Q3 2025, with capacity utilization below profitability.
- International sales for the German chemical and pharmaceutical industry weakened significantly in Q3 2025.
- A low unemployment rate of 3.9% in September 2025 indirectly supported consumer spending capacity.
Why did the price of Ivermectin change in September 2025 in Europe?
- Contracting industrial activity, with the Manufacturing Index contracting in September 2025, reduced demand.
- Weakening international sales for German chemical products in Q3 2025 increased supply pressure.
- Persistent high industry costs in Q3 2025 maintained upward pressure on production expenses.
